The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Dendritic cells (DCs) are crucial for mediating immune responses but, when deregulated, also contribute to immunological disorders, such as autoimmunity. The molecular mechanism underlying the function of DCs is incompletely understood. In this study, we have identified TANK-binding kinase 1 (TBK1), a master innate immune kinase, as an important regulator of DC function. DC-specific deletion of Tbk1 causes T cell activation and autoimmune symptoms and also enhances antitumor immunity in animal models of cancer immunotherapy. The TBK1-deficient DCs have up-regulated expression of co-stimulatory molecules and increased T cell–priming activity. We further demonstrate that TBK1 negatively regulates the induction of a subset of genes by type I interferon receptor (IFNAR). Deletion of IFNAR1 could largely prevent aberrant T cell activation and autoimmunity in DC-conditional Tbk1 knockout mice. These findings identify a DC-specific function of TBK1 in the maintenance of immune homeostasis and tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated critical roles for TBK1 and/or IKK ε in regulation of activity of numerous immune cell types, including T cells 21 , B cells 22,23 , dendritic cells 24 , and macrophages 25,26 .”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,400
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Liu, S., Cai, X., Wu, J., Cong, Q., Chen, X., Li, T., Du, F., Ren, J., Wu, Y.-T., Grishin, N. V., et al. (2015) · Science · doi:10.1126/science.aaa2630 · Cited by 1,927
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Woo, S.-R., Fuertes, M. B., Corrales, L., Spranger, S., Furdyna, M. J., Leung, M. Y. K., Duggan, R., Wang, Y., Barber, G. N., Fitzgerald, K. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.017 · Cited by 1,917
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G.-P., Lin, R., & Hiscott, J. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,661
Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., & Bhardwaj, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.233 · Cited by 1,359
Clinical use of dendritic cells for cancer therapy
Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F., & Berneman, Z. N. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70585-0 · Cited by 700
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Sharma, P., Wagner, K., Wolchok, J. D., & Allison, J. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3153 · Cited by 642 · cited 1×
“Although the tolerant function of DCs is important for preventing autoimmune diseases, it also poses a major obstacle for immune responses against cancer, and a general principal of cancer immunotherapy is to break immune tolerance (Sharma et al., 2011; Maueröder et al., 2014).”
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584 · cited 2×
“Akira (Osaka University, Osaka, Japan; Takeda et al., 1998), were crossed with CD11c-Cre transgenic mice to produce age-matched Stat3CD11c (termed WT) and Stat3 CD11c (termed Stat3-DKO) mice for experiments.”
Hemmi, H., Takeuchi, O., Sato, S., Yamamoto, M., Kaisho, T., Sanjo, H., Kawai, T., Hoshino, K., Takeda, K., & Akira, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040520 · Cited by 576
McWhirter, S. M., Fitzgerald, K. A., Rosains, J., Rowe, D. C., Golenbock, D. T., & Maniatis, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237236100 · Cited by 540
Triggering the Innate Antiviral Response through IRF-3 Activation
Hiscott, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700002200 · Cited by 458 · cited 2×
“TANK-binding kinase 1 (TBK1) along with its homologue IκB kinase epsilon (IKKε; also known as IKKi) are innate immune kinases that activate the transcription factor IRF3 and, thereby, mediate induction of type I IFNs by various PRR ligands during viral infections (Fitzgerald et al., 2003; Sharma et al., 2003; Hemmi et…”
BackgroundDalod, M., Chelbi, R., Malissen, B., & Lawrence, T. (2014) · The EMBO Journal · doi:10.1002/embj.201488027 · Cited by 437
Dudek, A. M., Martin, S., Garg, A. D., & Agostinis, P. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00438 · Cited by 399
Perry, A. K., Chow, E. K., Goodnough, J. B., Yeh, W.-C., & Cheng, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040528 · Cited by 399 · cited 1×
“TBK1 regulates T cell responses in dendritic cells | Xiao et al.1494 types and stimuli used (Perry et al., 2004).”
Clark, K., Plater, L., Peggie, M., & Cohen, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000414 · Cited by 385
Immature, but not inactive: the tolerogenic function of immature dendritic cells
Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H., & Jonuleit, H. (2002) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2002.01115.x · Cited by 384 · cited 4×
“Although it remains to be examined whether T reg function is impaired in the Tbk1-DKO mice, DCs are known to mediate immune tolerance by both promoting T reg cell induction and inducing T cell anergy (Mahnke et al., 2002).”
InfluentialBonnard, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.18.4976 · Cited by 381
A Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377
Self-citationType I interferon response and innate immune sensing of cancer
Fuertes, M. B., Woo, S.-R., Burnett, B., Fu, Y.-X., & Gajewski, T. F. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.004 · Cited by 375
Type I interferons: crucial participants in disease amplification in autoimmunity
Hall, J. C., & Rosen, A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.237 · Cited by 265
Chang, M., Jin, W., & Sun, S.-C. (2009) · Nature Immunology · doi:10.1038/ni.1777 · Cited by 256
Self-citationDendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function
Melillo, J. A., Song, L., Bhagat, G., Blazquez, A. B., Plumlee, C. R., Lee, C., Berin, C., Reizis, B., & Schindler, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902960 · Cited by 225 · cited 1×
“STAT3 deletion in DCs breaks immune tolerance and causes T cell activation in mice (Cheng et al., 2003; Melillo et al., 2010; Li et al., 2016).”
Shen, Y., Schlessinger, K., Zhu, X., Meffre, E., Quimby, F., Levy, D. E., & Darnell, J. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.407-419.2004 · Cited by 200 · cited 2×
“STAT3 is activated by inflammatory cytokines and type I IFNs via phosphorylation at both Y705 and S727 (Ng and Cantrell, 1997; Shen et al., 2004).”
Self-citationRegulation of T cell development by the deubiquitinating enzyme CYLD
Reiley, W. W., Zhang, M., Jin, W., Losiewicz, M., Donohue, K. B., Norbury, C. C., & Sun, S.-C. (2006) · Nature Immunology · doi:10.1038/ni1315 · Cited by 198 · cited 2×
“Cell suspensions were subjected to flow cytometry analyses as previously described (Reiley et al., 2006) using an LSR II flow cytometer (BD).”
Self-citationSTAT3 Negatively Regulates Type I IFN-Mediated Antiviral Response
Wang, W.-B., Levy, D. E., & Lee, C.-K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004128 · Cited by 178 · cited 2×
“In this regard, STAT3 has been shown to negatively regulate IFN responses and attenuate the induction of a subset of STAT1-target genes (Ho and Ivashkiv, 2010; Wang et al., 2011).”
Self-citationModeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 174 · cited 2×
“…the role of TBK1 in regulating immune responses, we examined the effect of DC-specific TBK1 deletion on tissue-specific autoimmunity using experimental autoimmune encephalomyelitis (EAE), an animal model of the autoimmune neuroinflammatory disease multiple sclerosis (Simmons et al., 2013).”
Innate signaling and regulation of Dendritic cell immunity
van Vliet, S. J., Dunnen, J. D., Gringhuis, S. I., Geijtenbeek, T. B., & van Kooyk, Y. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.05.006 · Cited by 170 · cited 1×
“DCs sense the environment largely via pattern-recognition receptors (PRRs), which recognize diverse molecular patterns associated with pathogens and commensal microbes, as well as self-ligands such as DNAs released from dying cells (van Vliet et al., 2007; Seya et al., 2010; Ahn and Barber, 2014).”
Baratin, M., Foray, C., Demaria, O., Habbeddine, M., Pollet, E., Maurizio, J., Verthuy, C., Davanture, S., Azukizawa, H., Flores-Langarica, A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.003 · Cited by 163
Kopp, E. B. (2004) · Medical Entomology and Zoology · Cited by 160
Molecular Control of Steady-State Dendritic Cell Maturation and Immune Homeostasis
Hammer, G. E., & Ma, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074929 · Cited by 154
Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease
Ahn, J., & Barber, G. N. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.009 · Cited by 144 · cited 1×
“DC-based cancer immunotherapy has become a promising approach of cancer treatment (Anguille et al., 2014).”
STAT3 Is a Serine Kinase Target in T Lymphocytes
Ng, J., & Cantrell, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24542 · Cited by 141
The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
Jin, J., Xiao, Y., Chang, J.-H., Yu, J., Hu, H., Starr, R., Brittain, G. C., Chang, M., Cheng, X., & Sun, S.-C. (2012) · Nature Immunology · doi:10.1038/ni.2423 · Cited by 136
Self-citationRegulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7074 · Cited by 118 · cited 4×
“…ligands, many other agents, such as inflammatory cytokines, the TNF superfamily of co-stimulatory factors, and T cell receptor stimuli, stimulate TBK1 activation, although not all of these agents induce type I IFN expression (Clark et al., 2009; Jin et al., 2012; Liu et al., 2015; Yu et al., 2015).”
InfluentialSelf-citationMayer, C. T., Berod, L., & Sparwasser, T. D. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00183 · Cited by 68
O’Shea, N. R., Chew, T. S., Dunne, J., Marnane, R., Nedjat-Shokouhi, B., Smith, P. J., Bloom, S. L., Smith, A. M., & Segal, A. W. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw111 · Cited by 53
Autoimmunity as a Double Agent in Tumor Killing and Cancer Promotion
Toomer, K. H., & Chen, Z. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00116 · Cited by 47 · cited 1×
“In fact, the same immune mechanisms that mediate autoimmunity also contribute to the destruction of tumors, with tumor immunotherapy often being viewed as intentional induction of autoimmune responses (Maueröder et al., 2014; Toomer and Chen, 2014).”
BackgroundPattern recognition receptors of innate immunity and their application to tumor immunotherapy
Seya, T., Shime, H., Ebihara, T., Oshiumi, H., & Matsumoto, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01442.x · Cited by 42 · cited 2×
“Activation of PRRs, particularly stimulator of IFN genes (STI NG), in DCs has been exploited as an approach to improve the efficiency of cancer immunotherapy (Seya et al., 2010; Woo et al., 2014).”
Tumor Immunotherapy: Lessons from Autoimmunity
Maueröder, C., Munoz, L. E., Chaurio, R. A., i, M. H., Schett, G. A., & Berens, C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00212 · Cited by 22 · cited 5×
“Although immune tolerance prevents the development of autoimmunity, it is a major mechanism by which cancer escapes from immune destruction (Maueröder et al., 2014).”
InfluentialLi, H. S., Liu, C., Xiao, Y., Chu, F., Liang, X., Peng, W., Hu, J., Neelapu, S. S., Sun, S.-C., Hwu, P., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aaf3957 · Cited by 22
Self-citationHo, H. H., & Ivashkiv, L. B. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0046 · Cited by 18
Isolation of Splenic Dendritic Cells Using Fluorescence-activated Cell Sorting
Tavernier, S. J., Osorio, F., Janssens, S., & Lambrecht, B. N. (2015) · BIO-PROTOCOL · doi:10.21769/bioprotoc.1415 · Cited by 5 · cited 2×
“Isolation of splenic dcs Splenic DCs were isolated essentially as described previously (Tavernier et al., 2015).”
Cited by
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Jenkins, R. W., Aref, A. R., Lizotte, P. H., Ivanova, E., Stinson, S., Zhou, C. W., Bowden, M., Deng, J., Liu, H., Miao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0833 · Cited by 594
“Another recent report demonstrated that TBK1 deletion, specifically in dendritic cells, also enhanced responsiveness to ICB therapy (55).”
BackgroundALS Genetics: Gains, Losses, and Implications for Future Therapies
Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
“Interestingly, while type 1 IFN production by dendritic cells themselves was attenuated, the broader interferon response was hyperactive in these animals and appeared to drive much of the phenotype, as crossing CD11c-Cre TBK1 mice to interferon alpha receptor 1 (IFNAR1)-KO mice essentially reversed the splenomegaly, l…”
BackgroundC9orf72 in myeloid cells suppresses STING-induced inflammation
McCauley, M. E., O’Rourke, J. G., Yáñez, A., Markman, J. L., Ho, R., Wang, X., Chen, S., Lall, D., Jin, M., Muhammad, A. K. M. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2625-x · Cited by 298
Targeting TBK1 to overcome resistance to cancer immunotherapy
Sun, Y., Revach, O.-Y., Anderson, S., Kessler, E. A., Wolfe, C. H., Jenney, A., Mills, C. E., Robitschek, E. J., Davis, T. G. R., Kim, S., et al. (2023) · Nature · doi:10.1038/s41586-023-05704-6 · Cited by 174
Metadata
- Authors
- Xiao, Y., Zou, Q., Xie, X., Liu, T., Li, H. S., Jie, Z., Jin, J., Hu, H., Manyam, G., Zhang, L., Cheng, X., Wang, H., Marie, I., Levy, D. E., Watowich, S. S., & Sun, S.-C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- NYU Langone Health (US)
- Corresponding author
- Sun, Shao-Cong
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-03-29
- Volume
- 214
- Issue
- 5
- Pages
- 1493-1507
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5413337
- OpenAlex
- W2600881183
- Cited by
- 87
- References
- 47
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 12 · 2023: 4 · 2022: 14 · 2021: 15 · 2020: 9 · 2019: 9 · 2018: 5 · 2017: 5
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Cancer Prevention and Research Institute of Texas (RP150235)
- National Institutes of Health (GM84459)
- MD Anderson Cancer Center
- National Natural Science Foundation of China (81571545)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TBK1, dendritic cells, T cell homeostasis, autoimmunity, antitumor immunity, type I interferon receptor, IFNAR1, T cell activation, costimulatory molecules, innate immunity, immune tolerance, cancer immunotherapy
- MeSH terms
- Animals, Dendritic Cells, Homeostasis, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Autoimmunity, Protein Serine-Threonine Kinases, Mice, Knockout, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.